echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Blood System > JCO: Arsenic combined with all-trans retinoic acid can safely and effectively treat Chinese APL pediatric patients!

    JCO: Arsenic combined with all-trans retinoic acid can safely and effectively treat Chinese APL pediatric patients!

    • Last Update: 2021-06-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Acute promyelocytic leukemia (APL) is a subtype of acute myeloid leukemia and is relatively rare in the pediatric population.


    It is relatively rare in the pediatric population.


    This is a multi-center clinical trial conducted in 38 hospitals in China, recruiting newly diagnosed APL patients, and dividing the tested patients into two risk groups based on the basic WBC count and FLT3-TID mutation.


    A and B: overall survival rate; C and D: event-free survival rate; E and F: cumulative recurrence rate

    A and B: overall survival rate; C and D: event-free survival rate; E and F: cumulative recurrence rate

    A total of 193 APL patients were recruited.


    After a median follow-up of 28.


    In summary, arsenic combined with ATRA is effective and safe for children with APL , but long-term follow-up is still needed .


    Arsenic combined with ATRA is effective and safe for children with APL , but long-term follow-up is still required.


    Original source:

    Huyong Zheng, et al.


    Arsenic Combined With All-Trans Retinoic Acid for Pediatric Acute Promyelocytic Leukemia: Report From the CCLG-APL2016 Protocol Study

    in this message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.